According to ChemAnalyst, the global Amphotericin B Prices market recorded a generally firm but measured trend during the quarter ending June 2026. Prices increased across the United States, China, India and Germany, although the magnitude of movement varied by region. The market was influenced by marginal cost-pass-through, logistics expenses, compliance costs, energy costs, import delays and changes in regional supply availability.
In the United States, the Amphotericin B Price Index rose by 0.27% quarter-over-quarter, reflecting marginal cost-push pressures. The average Amphotericin B price for the quarter was approximately USD 651896.67/MT, reflecting marginal logistics and compliance cost pass-through.
China also experienced a modest increase. The Amphotericin B Price Index rose by 0.26% quarter-over-quarter, reflecting marginal cost pass-through. The average Amphotericin B price was approximately USD 651666.67/MT, based on FOB Shanghai totals.
India recorded a stronger increase than the other assessed markets. The Amphotericin B Price Index rose by 1.97% quarter-over-quarter, reflecting a tighter import balance. The Amphotericin B Spot Price pushed the Price Index higher as import delays tightened bulk availability.
Germany followed the broader global upward trend, with the Amphotericin B Price Index rising by 0.26% quarter-over-quarter, fueled by energy and offers. The average Amphotericin B price was approximately USD 651810/MT, reported CFR Hamburg.
Overall, Q2 2026 reflected a stable-to-firm market, with relatively small price movements in the United States, China and Germany and a more noticeable increase in India.
Amphotericin B Prices in North America
The North American Amphotericin B Price Trend remained slightly firm during Q2 2026.
In the United States, the Amphotericin B Price Index increased by 0.27% quarter-over-quarter, reflecting marginal cost-push pressures.
The average Amphotericin B price for the quarter was approximately USD 651896.67/MT.
The movement was associated with marginal logistics and compliance cost pass-through. For specialized pharmaceutical products, compliance requirements can form an important part of the overall commercial cost structure. Changes in logistics expenses can also affect the final price when products require controlled handling and specialized transportation.
The relatively small quarterly increase indicates that these cost pressures translated into a measured rather than aggressive rise in U.S. pricing.
Amphotericin B Price Trend in the United States
The Amphotericin B Price Trend in the USA increased by 0.27% quarter-over-quarter during Q2 2026.
The average price reached approximately USD 651896.67/MT, reflecting marginal logistics and compliance cost pass-through.
The market therefore remained broadly stable, with only a slight upward adjustment. Cost-push pressure was sufficient to move the Price Index higher, but the increase remained limited.
For pharmaceutical procurement teams, even relatively small percentage changes can be relevant when dealing with high-value pharmaceutical ingredients. Monitoring logistics and compliance-related costs can therefore help buyers understand changes in the final procurement price.
Logistics and Compliance Costs
Logistics and compliance costs were important contributors to U.S. Amphotericin B Prices during Q2 2026.
The supplied market assessment indicates that these costs were passed through marginally to buyers, supporting the 0.27% quarter-over-quarter increase in the Price Index.
Specialized pharmaceutical materials can require stringent quality and handling procedures. Consequently, changes in logistics and compliance expenses can influence the total commercial cost even when the underlying product market remains relatively stable.
The average price of USD 651896.67/MT reflected these marginal cost pressures.
Get Real Time Online for Amphotericin B Prices: https://www.chemanalyst.com/Pricing-data/amphotericin-b-1447
Amphotericin B Prices in APAC
The APAC Amphotericin B Prices market remained broadly stable-to-firm during Q2 2026.
In China, the Amphotericin B Price Index rose by 0.26% quarter-over-quarter, reflecting marginal cost pass-through.
The average Amphotericin B price for the quarter was approximately USD 651666.67/MT, based on FOB Shanghai totals.
The modest increase suggests that producers and exporters experienced some upward cost pressure but that the impact on overall market pricing remained limited.
FOB Shanghai assessments provide an export-oriented reference point for the Chinese market and capture pricing conditions before the product reaches the importing destination.
Amphotericin B Price Trend in China
The Amphotericin B Price Trend in China increased by 0.26% quarter-over-quarter during Q2 2026.
The average price was approximately USD 651666.67/MT based on FOB Shanghai totals.
Marginal cost pass-through was the key factor supporting the increase.
The limited price movement indicates that the Chinese market remained relatively balanced despite the presence of cost pressures. Suppliers adjusted offers moderately rather than implementing substantial price increases.
China's position as an export-oriented market also means that international procurement conditions can influence the level and direction of FOB offers.
Cost Pass-Through in the Chinese Market
Cost pass-through played an important role in China's Amphotericin B Price Trend.
When producers face higher operating or input expenses, they may attempt to transfer part of those costs into selling prices. In Q2 2026, this process resulted in a 0.26% quarter-over-quarter increase in China's Price Index.
The average price of USD 651666.67/MT FOB Shanghai reflected the relatively moderate nature of the increase.
The market consequently remained firm without showing signs of a sharp upward price movement.
Amphotericin B Prices in India
India recorded the strongest quarterly increase among the assessed regions.
The Indian Amphotericin B Price Index rose by 1.97% quarter-over-quarter, reflecting a tighter import balance.
Unlike the relatively small increases observed in the United States, China and Germany, India's market experienced a more pronounced supply-side influence.
The Amphotericin B Spot Price pushed the Price Index higher as import delays tightened bulk availability.
Import-dependent markets can be particularly sensitive to delays because interruptions in incoming cargoes may reduce immediately available stocks. When buyers compete for limited prompt material, spot prices can strengthen.
Amphotericin B Spot Price in India
The Amphotericin B Spot Price remained an important driver of the Indian market during Q2 2026.
Import delays tightened bulk availability, pushing the Spot Price higher and subsequently lifting the broader Price Index.
The 1.97% quarter-over-quarter increase therefore reflected tighter import balance rather than merely marginal cost pass-through.
The development highlights the importance of logistics and cargo timing in pharmaceutical ingredient markets. Even when overall production remains stable, delays in imports can temporarily restrict physical availability and affect spot-market pricing.
Import Delays and Bulk Availability
Import delays created additional pressure on India's Amphotericin B Prices during Q2 2026.
When cargoes are delayed, buyers may have fewer prompt volumes available for immediate procurement. This can create short-term competition for existing inventory.
In India, the resulting tightening in bulk availability pushed the Amphotericin B Spot Price higher.
The effect was reflected in the 1.97% quarter-over-quarter increase in the Price Index.
Future price direction in India will therefore remain closely linked to import schedules, cargo availability and the normalization of supply flows.
Amphotericin B Prices in Europe
The European Amphotericin B Price Trend remained firm during Q2 2026.
In Germany, the Amphotericin B Price Index rose by 0.26% quarter-over-quarter, fueled by energy and offers.
The average Amphotericin B price for the quarter was approximately USD 651810/MT, reported CFR Hamburg.
The movement was modest but consistent with the wider global trend of slight price increases.
Energy costs can affect manufacturing economics, while supplier offers reflect current market conditions and replacement costs. Together, these factors contributed to the marginal increase observed in Germany.
Book A Demo for Amphotericin B Price: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Amphotericin%20B
Amphotericin B Price Trend in Germany
Germany's Amphotericin B Price Index increased by 0.26% quarter-over-quarter during Q2 2026.
The average price was approximately USD 651810/MT CFR Hamburg.
Energy and supplier offers fueled the increase, although the overall movement remained limited.
The German market therefore displayed a relatively stable pricing environment, with cost pressures generating only a marginal upward adjustment.
For European buyers, monitoring energy expenses and supplier offers can provide useful indications of potential changes in pharmaceutical ingredient procurement costs.
Energy Costs and Supplier Offers
Energy costs were identified as an important factor supporting Germany's Amphotericin B Prices during Q2 2026.
Higher energy-related expenses can raise manufacturing and processing costs, which may subsequently be reflected in supplier offers.
The combination contributed to the 0.26% quarter-over-quarter increase in Germany's Price Index.
The average price of USD 651810/MT CFR Hamburg represented the market assessment during the quarter.
Amphotericin B Demand Analysis
The Amphotericin B demand outlook remained relatively stable during Q2 2026, with price changes appearing to be driven more by cost and supply-side conditions than by major demand fluctuations.
The United States recorded a 0.27% quarter-over-quarter increase, while China and Germany each recorded 0.26% increases.
India experienced a larger 1.97% increase, primarily because import delays tightened bulk availability.
The relatively limited movement in three of the four assessed markets suggests that demand conditions did not generate substantial additional upward pressure during the quarter.
Amphotericin B Supply Analysis
Supply conditions were particularly important in India's market.
Import delays reduced bulk availability and pushed the Amphotericin B Spot Price higher, resulting in a 1.97% quarter-over-quarter increase in India's Price Index.
In contrast, the United States, China and Germany experienced more moderate movements associated with logistics, compliance, cost pass-through, energy and supplier offers.
The regional differences demonstrate how the same global product can experience different pricing dynamics depending on local supply-chain conditions.
Key Factors Influencing Amphotericin B Prices
Several factors influenced global Amphotericin B Prices during Q2 2026.
Logistics Costs
Marginal logistics cost pass-through contributed to the U.S. price increase.
Compliance Costs
Compliance costs also supported higher U.S. pricing.
Cost Pass-Through
China's 0.26% quarter-over-quarter increase reflected marginal cost pass-through.
Import Balance
India's tighter import balance supported its stronger quarterly increase.
Import Delays
Delays in incoming cargoes tightened bulk availability in India.
Spot Prices
The Indian Amphotericin B Spot Price pushed the broader Price Index higher.
Energy Costs
Higher energy-related costs supported the German market's upward movement.
Supplier Offers
Supplier offers contributed to the increase in Germany.
Regional Amphotericin B Price Comparison
The Q2 2026 Amphotericin B Prices market can be summarized as follows:
United States: The Amphotericin B Price Index rose by 0.27% quarter-over-quarter. The average price was approximately USD 651896.67/MT, reflecting marginal logistics and compliance cost pass-through.
China: The Amphotericin B Price Index rose by 0.26% quarter-over-quarter. The average price was approximately USD 651666.67/MT FOB Shanghai, reflecting marginal cost pass-through.
India: The Amphotericin B Price Index rose by 1.97% quarter-over-quarter, reflecting tighter import balance. Import delays tightened bulk availability and pushed the Amphotericin B Spot Price higher.
Germany: The Amphotericin B Price Index rose by 0.26% quarter-over-quarter, fueled by energy and offers. The average price was approximately USD 651810/MT CFR Hamburg.
India recorded the strongest increase, while the other three assessed markets showed only marginal upward movements.
Amphotericin B Market Outlook
The Amphotericin B market outlook will depend on logistics, import availability, production costs, energy expenses, supplier offers and compliance-related costs.
In the United States, the future direction of prices will depend on whether logistics and compliance costs continue to generate cost-pass-through pressure.
China's market will remain sensitive to production costs and exporters' ability to pass through marginal increases.
India will remain particularly sensitive to import flows. If import delays continue, bulk availability could remain constrained and keep spot prices firm. Conversely, improved cargo flows could reduce supply pressure.
Germany's outlook will depend on energy costs and supplier offers, with changes in either factor capable of influencing the regional Price Index.
Amphotericin B Price Forecast
The Amphotericin B Price Forecast points toward a market where logistics and supply-chain conditions will remain important determinants of price direction.
U.S. prices could remain stable-to-firm if logistics and compliance expenses continue to be passed through.
China's market could experience measured price movements if cost pressures remain marginal.
India has comparatively greater potential for short-term volatility because import delays can quickly affect bulk availability and Spot Prices.
Germany's price direction will remain connected to energy costs and supplier offers.
Procurement teams should therefore monitor import schedules, bulk availability, logistics expenses, compliance costs, energy prices, supplier offers and production costs when evaluating future Amphotericin B prices.
Amphotericin B Price Trend: Key Takeaways
The Q2 2026 Amphotericin B Price Trend can be summarized as follows:
The U.S. Amphotericin B Price Index rose by 0.27% quarter-over-quarter.
The U.S. average price was approximately USD 651896.67/MT.
Marginal logistics and compliance cost pass-through supported U.S. pricing.
China's Amphotericin B Price Index increased by 0.26% quarter-over-quarter.
China's average price was approximately USD 651666.67/MT FOB Shanghai.
Marginal cost pass-through supported China's increase.
India's Amphotericin B Price Index increased by 1.97% quarter-over-quarter.
Tighter import balance supported India's price increase.
Import delays tightened bulk availability.
Amphotericin B Spot Price pushed India's Price Index higher.
Germany's Amphotericin B Price Index rose by 0.26% quarter-over-quarter.
Germany's average price was approximately USD 651810/MT CFR Hamburg.
Energy and supplier offers supported Germany's upward movement.
India recorded the strongest quarterly increase among the assessed markets.
Conclusion
The global Amphotericin B Prices market remained stable-to-firm during the quarter ending June 2026, with all assessed regions recording moderate increases. However, the drivers and intensity of price movements differed across markets.
In the United States, the Amphotericin B Price Index rose by 0.27% quarter-over-quarter, with the average price reaching approximately USD 651896.67/MT. Marginal logistics and compliance cost pass-through supported the increase.
In China, the Price Index increased by 0.26% quarter-over-quarter, with the average price at approximately USD 651666.67/MT FOB Shanghai. The movement reflected marginal cost pass-through.
In India, the Price Index rose by 1.97% quarter-over-quarter, representing the strongest increase among the assessed markets. A tighter import balance and import delays reduced bulk availability, pushing the Amphotericin B Spot Price higher.
In Germany, the Price Index increased by 0.26% quarter-over-quarter, while the average price reached approximately USD 651810/MT CFR Hamburg. Energy costs and supplier offers fueled the increase.
Overall, Q2 2026 demonstrated a measured upward Amphotericin B Price Trend, with logistics, compliance costs, cost pass-through, import balance, import delays, bulk availability, energy costs and supplier offers serving as the principal market factors. Monitoring these variables will remain essential for pharmaceutical manufacturers, buyers, distributors and procurement professionals evaluating future Amphotericin B market conditions.
ChemAnalsyt
Call +1 3322586602
420 Lexington Avenue, Suite 300, New York, NY, United States, 10170
Website: https://www.chemanalyst.com/
Email: sales@chemanalyst.com
この記事をシェア
